ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2022 and some content may be unavailable. To unlock all content for 2022, please visit the archives.

Abstract: FR-PO908

Computer-Based Renal Sonographic Image Analysis on Renal Progression in Patients With Chronic Glomerulopathies

Session Information

Category: CKD (Non-Dialysis)

  • 2201 CKD (Non-Dialysis): Epidemiology‚ Risk Factors‚ and Prevention

Authors

  • Chanlerdfa, Nuntanutch, Phramongkutklao College of Medicine, Bangkok, Thailand
  • Chaiprasert, Amnart, Phramongkutklao College of Medicine, Bangkok, Thailand
  • Nata, Naowanit, Phramongkutklao College of Medicine, Bangkok, Thailand
  • Tasanavipas, Pamila, Phramongkutklao College of Medicine, Bangkok, Thailand
  • Varothai, Narittaya, Phramongkutklao College of Medicine, Bangkok, Thailand
  • Thimachai, Paramat, Phramongkutklao College of Medicine, Bangkok, Thailand
  • Inkong, Pitchamon, Phramongkutklao College of Medicine, Bangkok, Thailand
  • Kaewput, Wisit, Phramongkutklao College of Medicine, Bangkok, Thailand
  • Supasyndh, Ouppatham, Phramongkutklao College of Medicine, Bangkok, Thailand
  • Satirapoj, Bancha, Phramongkutklao College of Medicine, Bangkok, Thailand
Background

Renal sonography is useful diagnostic imaging procedure in chronic glomerulopathies. Quantitative renal echogenicity has not been formerly evaluated regarding its capacity to identify patients at risk for progressive renal disease.

Methods

Renal sonography was performed in 79 patients with chronic kidney disease (CKD) including 37 patients with chronic glomerulonephritis (CGN) undergoing renal biopsy and 42 patients with other glomerulopathies. Sonographic images were processing and analysis by computer programs to determine quantitative renal cortical echogenicity. Patients were followed during a three-month period to evaluated renal progression with estimated glomerular filtration rate (GFR).

Results

Among 79 patients, 31 (39.24%) patients had renal progression. In patients with CGN undergoing renal biopsy, total renal cortical echogenicity and long axis echogenicity was significantly higher than patients without renal progression. In the multivariable analysis, high renal echogenicity remained significantly associated with increased risk of worsening renal function in CGN patients (HR 1.13, 95%CI 1.01-1.25). Long axis renal echogenicity (AUC 0.71; 95%CI 0.52 to 0.89), combining with other findings (AUC 0.93; 95%CI 0.84 to 1.00) achieved a better score predicting CKD progression in CGN group. Furthermore, renal to liver echogenicity ratio was significantly correlated with interstitial fibrosis and tubular atrophy. Renal/liver echogenicity ratio (AUC 0.83; 95%CI 0.69 to 0.97), combining with other findings (AUC 0.95; 95%CI 0.88 to 1.00) achieved a perfect score predicting IFTA>50% in CGN group.

Conclusion

Quantitative renal cortical echogenicity by computer based image analysis might be a useful tool to identify CGN patients with renal progression and related to renal fibrosis.